<DOC>
	<DOCNO>NCT02452801</DOCNO>
	<brief_summary>This study evaluate effect various degree hepatic function pharmacokinetics safety ALKS 5461 .</brief_summary>
	<brief_title>Pharmacokinetics Safety ALKS 5461 Healthy Subjects Subjects With Hepatic Impairment Normal Hepatic Function</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>For subject : Has body mass index ( BMI ) 18.035.0 kg/m2 total body weight &gt; 50 kg Agrees use approve method contraception duration study Additional criterion may apply For subject hepatic impairment : Has mild , moderate , severe hepatic impairment Has hepatic dysfunction due hepatocellular disease Additional criterion may apply For subject : Has past history current finding clinically significant observed abnormality , psychiatric medical condition hepatic impairment Has history gastrointestinal surgery , exclude appendectomy cholecystectomy Is pregnant , plan become pregnant , lactate Has history clinically significant allergy hypersensitivity opioids Additional criterion may apply For subject hepatic impairment : Has evidence hepatocellular carcinoma , acute liver disease , biliary obstruction , severe ascites , severe portal hypertension , surgical systemic shunt , clinically relevant liverrelated disorder condition Has receive liver transplant Has esophageal variceal bleed past 2 month Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>